Ubiquitination: A Double‐Edged Mechanism in Coronavirus Infections
Journal of Medical Virology · 2025
DOI: 10.1002/jmv.70589 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von Sijie Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology, School of Life Sciences, Central South University, Changsha, China. Hauptthemen laut MEDLINE: Ubiquitination, SARS-CoV-2, COVID-19. Die Arbeit nennt 208 Literaturangaben. Gefördert von: This study was supported by the National Natural Science Foundation of China (U21A20384), the Science and Technology Innovation Program of Hunan Province (2024….
Abstract (Originalsprache)
The emergence of SARS‐CoV‐2 in late 2019 had a profound impact on public health, leading to the global COVID‐19 pandemic. This viral outbreak has significantly heightened interest in coronaviruses, accelerating research into their pathogenesis. Ubiquitination, a common Posttranslational protein modification, plays a crucial role in processes such as protein localization, metabolism, and degradation. During coronavirus invasion and disease progression, complex interactions involving ubiquitination are at play. On one hand, the host utilizes ubiquitination to activate innate immune signaling pathway or degrade crucial viral proteins via the ubiquitin‐proteasome pathway, thereby inhibiting viral replication. On the other hand, coronaviruses manipulate ubiquitination to suppress the activation of key antiviral molecules or promote their degradation. Thus, both the host and virus leverage ubiquitination to their advantage. Thus, investigating the role of ubiquitination in coronavirus infection provides crucial insights into viral infection mechanisms and pathogenesis, potentially facilitating the development of novel antiviral drugs, particularly those targeting ubiquitination regulation, such as PROTAC. This paper offers a comprehensive examination of the regulatory function of ubiquitination in coronavirus infection, with the potential to advance research in the field and open new avenues for the effective control of coronaviruses, especially SARS‐CoV‐2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell Biology, School of Life Sciences, Central South University, Changsha, China.
- Xiangya School of Medicine, Central South University, Changsha, China.
- Xiangya School of Public Health, Central South University, Changsha, China.
- Hunan Provincial Key Laboratory of Neurorestoratology, 921 Hospital of Joint Logistics Support Force People's Liberation Army of China (The Second Affiliated Hospital of Hunan Normal University), Changsha, China.
- Xiangya School of Pharmaceutical Science, Central South University, Changsha, China.
- Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, China.
ORCID-Profile: Zanxian Xia
Förderung
- This study was supported by the National Natural Science Foundation of China (U21A20384), the Science and Technology Innovation Program of Hunan Province (2024…
Zitieren
APA
Liu, S., Shao, C., Ding, Y., Wang, Y., Jin, L., Tan, D. A., Li, S., Deng, X., Zhou, Y., & Xia, Z. (2025). Ubiquitination: A Double‐Edged Mechanism in Coronavirus Infections. Journal of Medical Virology. https://doi.org/10.1002/jmv.70589
Vancouver
Liu S, Shao C, Ding Y, Wang Y, Jin L, Tan DA, et al. Ubiquitination: A Double‐Edged Mechanism in Coronavirus Infections. Journal of Medical Virology. 2025. doi:10.1002/jmv.70589
BibTeX
@article{Liu2025,
author = {Liu, Sijie and Shao, Chuhan and Ding, Yina and Wang, Yuxuan and Jin, Liangyin and Tan, De-An and Li, Shanni and Deng, Xu and Zhou, Yuzheng and Xia, Zanxian},
title = {Ubiquitination: A Double‐Edged Mechanism in Coronavirus Infections},
journal = {Journal of Medical Virology},
year = {2025},
doi = {10.1002/jmv.70589}
}
EUVIMED